PP
FMS icon

Paloma Partners’s Fresenius Medical Care FMS Stock Holding History

Paloma Partners’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,509
Closed -$203K – 1510
2019
Q4 		$203K Buy
+5,509
New +$195K ﹤0.01% 1968

Other funds holding FMS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Paloma Partners's FMS Position: Q1 2020 in Review

Paloma Partners sold out of Fresenius Medical Care (FMS) in Q1 2020, closing a stake of 5,509 shares — an estimated $203K sold.

Paloma Partners first reported a position in FMS in Q4 2019 and held it in 1 quarter. The position peaked at $203K in Q4 2019. 177 funds tracked by Wall St. Rank hold FMS as of Q1 2020.

  • Paloma Partners reported no remaining Fresenius Medical Care position as of Q1 2020 after selling out during the quarter.
  • Paloma Partners sold 5,509 Fresenius Medical Care shares in Q1 2020, an estimated $203K.
  • Paloma Partners first reported a position in Fresenius Medical Care in Q4 2019 and held it in 1 quarter.
  • Paloma Partners's Fresenius Medical Care position peaked at $203K in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2020.

Based on Paloma Partners's 13F filing for Q1 2020, filed 15 May 2020.